Public Market Listing
6875TPEx
Live quotes, historical charts, and market capitalization for Pharmosa Biopharm Inc. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | IP receptor (prostacyclin pathway)Small molecule | Pulmonary Arterial HypertensionPulmonary Hypertension Associated with Interstitial Lung Disease |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2029 (1)
July 2029 (1)
Est. primary completion 2029-07 · NCT07285655 · CT.gov ↗
What to watch
Financial reports
No financial reports recorded.